GENEVA, March 31 -- ALLOGENE THERAPEUTICS, INC. (210 East Grand AvenueSouth San Francisco, California 94080) filed a patent application (PCT/US2025/047372) for "CD19 ANTI-IDIOTYPIC ANTIBODIES" on Sep 22, 2025. With publication no. WO/2026/064719, the details related to the patent application was published on Mar 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MELTON, Zea (1070 Rio Vista DrivePacifica, California 94044), CHENG, Hsin-Yuan (3345 Marisma StreetSan Mateo, California 94403)
Abstract: Provided herein are anti-idiotype antibodies that specifically recognize anti-CD19 antibody m...